Aprepitant Capsules recall
Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430.…
Why was Aprepitant Capsules recalled?
Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot: 17180918, EXP June 2020
- Product
- Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430.…
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA
- Quantity
- 5,016 blister packs
- Distribution
- Nationwide
- Recall date
- December 26, 2018
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)